Dr. Millili is currently Senior Principal Technical Advisor at Genentech (A member of the Roche Group) in the Compliance and External Collaboration Department where he is responsible for external collaboration for the Americas. Prior to this position, George was employed by Merck where he held leadership positions as Senior Director of Pharmaceutical Commercialization Development and Technical Operations in Latin America and Puerto Rico.
Prior to Merck, George was Senior Director of Pharmaceutical Technology Services for GPSG, a division of Johnson and Johnson where he led a group responsible for new product introduction, packaging development, marketed product support and validation of new and existing technologies. George also was employed by DuPont Merck Pharmaceuticals as Executive Director, worldwide Manufacturing technology.
George’s specialty areas of interest are Product Development, Scale-up and Technology Transfer of Pharmaceutical products. He has a Bachelor’s degree in Pharmacy from Temple University and a PH.D. In Pharmaceutics from the Philadelphia College of Pharmacy and Sciences. George has been an active member of ISPE throughout the years and currently is Global Co-Chair of the ISPE Regulatory and Quality Harmonization committee (RQHC). He also previously served as chair of the Global PQLI technical committee and numerous other committees in the association. George also co-lead an industry wide team that developed and published an ISPE Good Practice Guide on Process Performance and Product Quality Monitoring Systems. In 2015, George was awarded the ISPE Joseph X. Phillips Professional Achievement Award for his contributions to ISPE and Industry.